ReviewFood science & nutrition2026
Nanomaterials in Edible Mushroom Production: Yield Optimization, Biofortification and SDG Alignment.
Review in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Edible mushrooms are increasingly recognized as nutrient-dense functional foods and integral components of sustainable circular bioeconomy systems. Nano-enabled strategies, such as nano-fertilizers, nano-elicitors, and substrate amendments, significantly improve mycelial growth, nutrient uptake, and biological efficiency when applied at optimized low concentrations. Zinc oxide and selenium nanoparticles were identified as effective agents for increasing yield and enhancing micronutrient content, highlighting their role in nano-biofortification. Postharvest applications, particularly chitosan-based nano-coatings and nanocomposite films, were shown to reduce enzymatic browning, microbial spoilage, and moisture loss, thereby extending shelf life and minimizing postharvest losses. At the mechanistic level, nanomaterials influence fungal physiology through controlled nutrient delivery, modulation of reactive oxygen species (ROS), enzyme activation, and improved substrate interactions. Furthermore, mushrooms contribute to sustainable nanotechnology through myco-mediated nanoparticle synthesis and the valorization of spent mushroom substrate into biochar and other value-added products, supporting circular economy principles. However, several challenges remain, including dose-dependent toxicity, potential nanoparticle accumulation in edible tissues, environmental persistence and the absence of standardized application protocols. Regulatory frameworks and long-term safety assessments are essential for responsible adoption. In conclusion, nanotechnology offers a promising pathway to enhance productivity, nutritional quality, and sustainability in mushroom production systems while contributing to SDGs 2, 3, 12, and 13. Future research should emphasize large-scale validation, life-cycle assessment, and the development of safe-by-design nanomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.